Partial androgen deficiency, depression and testosterone treatment in aging men
Mario Amore1, Fabiano Scarlatti1, Antonio Lucio Quarta1 and Pietro Tagariello2
1Institute of Psychiatry, Department of Neurosciences, University of Parma, 2Department of Mental Health, Bufalini Hospital, Cesena, Italy

Abstract

This study provides a critical review of the literature on depressive symptoms of partial androgen deficiency (PADAM) and their treatment with Testosterone (T). PADAM in aging males is responsible for a variety of behavioral symptoms, such as weakness, decreased libido and erectile dysfunction, lower psychological vitality, depressive mood, anxiety, insomnia, difficulty in concentrating, and memory impairment. The psychological and behavioural aspects of PADAM may overlap with signs and symptoms of major depression. Evidence of the relationship between androgen deficiency and male depression comes from studies that have assessed depression in hypogonadal subjects, the association between low T level and male depressive illness, and the antidepressant action of androgen replacement. The etiology of depressive symptoms of PADAM is multifactorial, and results from the interaction of the biological and psychosocial changes that take place during the mid-life transition. Although data derived from androgen treatment trials and androgen replacement do not support T treatment or replacement as more efficacious than placebo for major depressive disorder (MDD), the clinical impression is that, in some sub-threshold depressive syndromes, T may lead to antidepressant benefits. (Aging Clin Exp Res 2009; 21: 1-8) ©2009, Editrice Kurtis

[« Back] [Not subscriber] [Subscriber] [Order printable]